Aerie Pharmaceuticals, Inc. Share Price
Equities
AERI
US00771V1089
Pharmaceuticals
Managers | Title | Age | Since |
---|---|---|---|
David Endicott
CEO | Chief Executive Officer | 58 | 20/11/22 |
Andrew Allen
CMP | Compliance Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 28/02/22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Ian Bell
BRD | Director/Board Member | 54 | 20/11/22 |
Chairman | 57 | 20/11/22 | |
Jonathan Balch
BRD | Director/Board Member | - | 20/11/22 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.02% | 430 M€ | -.--% |
1st Jan change | Capi. | |
---|---|---|
+42.92% | 748B | |
+34.11% | 598B | |
-5.70% | 356B | |
+17.94% | 325B | |
+4.58% | 283B | |
+17.02% | 245B | |
+9.26% | 211B | |
-4.21% | 209B | |
+2.42% | 166B |